Tiamulin hydrogen
Sold as Respalin premix, Tiamulin premix huve
[(1S,2R,3S,4S,6R,7R,8R,14R)-4-Ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl] 2-[2-(diethylamino)ethylsulfanyl]acetate
Drag to rotate. Structure from PubChem CID 656958.
Background
Registration
- Applicants
- 2
- Registrations
- 2
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Kyron Animal Health (Pty) Ltd | Respalin premix | 10 % | 14/11 | Not determined | None |
| Huvepharma South Africa (Pty) Ltd | Tiamulin premix huve | 100 mg/g | 19/13 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Respalin 10 % premix EACH 1,0 ml CONTAINS: TIAMULIN HYDROGEN FUMARATE 1,0 mg | 10 % | 14/1114/17.1.10/11 | Registered | Not determined | None |
| Tiamulin 100 mg/g premix huve Each 1,0 g Premix contains: Tiamulin Hydrogen Fumarate 100,0 mg | 100 mg/g | 19/1319/17.1/13 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.